A New Standard of Care. ASTRO 2017 Update (NASDAQ: VRAY) 1
|
|
- Randolph Hancock
- 6 years ago
- Views:
Transcription
1 A New Standard of Care ASTRO 2017 Update (NASDAQ: VRAY) 1
2 Disclaimer Forward-Looking Statements This presentation may contain forward-looking statements that are based on our current expectations of the market and regulatory environments, estimates and projections about our industry as well as management s beliefs and assumptions. Words such as anticipates, expects, intends, plans, believes, seeks, estimates, may, will and variations of these words or similar expressions are intended to identify forward-looking statements. These statements include projections about the growth of the market for radiation oncology, and speak only as of the date hereof. Such statements are based upon the information available to us now and are subject to change. We will not necessarily inform you of such changes. Unless the context requires otherwise, references to ViewRay, the company, we, us and our refer to ViewRay, Inc. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Therefore, actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors. Factors which could cause actual results to differ materially from those in the forward-looking statements include, among others, the availability of competitive alternatives to our products, domestic or international economic uncertainty and other events beyond our control. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure set forth in the reports and other documents ViewRay files with the SEC, available at 2
3 5 key takeaways 3+ years of clinical experience show clear advantages of MRI guided RT Only system to adapt and reshape the dose with patient on-table Unique 4 Tesla quality imaging at the right (RT) field strength for therapy Henry Ford Health Center treating with MRIdian Linac since July Reiterating guidance of $45-$50M on 7-8 systems by year end ViewRay believes that we will enable a new standard of cancer care. 3
4 This is why it matters Can you believe, without ViewRay Clinicians are blind while delivering radiation X-rays cannot see soft tissue tumors Now ViewRay has a patented solution: MRIdian Linac MRIdian users see how tumors & organs change shape Radiation Oncologists can see and adapt like a surgeon 4
5 This is why it matters Can you believe, without ViewRay Clinicians are blind while delivering radiation X-rays cannot see soft tissue tumors Now ViewRay has a patented solution: MRIdian Linac MRIdian users see how tumors & organs change shape Radiation Oncologists can see and adapt like a surgeon * Henry Ford Cancer Institute 5
6 ViewRay investment opportunity Right Breast Mediastinum Head/Neck Right Lung Bladder Mesenteric Aortic Arch World s only commercially available MRI-guided radiation treatment system First 9 systems proved breakthrough is real Hilum Soft Tissue ABD Pancreas Mediastinal LN Adrenal Rib Pelvic LN FDA clearance of MRIdian Linac transforms profitability profile 25 Systems, $144.9M in Backlog Paraaortic Liver Iliac Stomach Spine Soft Tissue Neck Left Lung $3.7 billion radiation oncology opportunity Spleen Colon Periaortic Left Breast 6 Prostate Soft Tissue Pelvis Rectum Confidential Information 1
7 Confidential Information 7
8 * Washington University Here s how MRIdian makes a difference Cone-beam CT Align MRIdian - MRI Adapt MRIdian - On-table Adapting FX 1 ADAPTED FX 2 ADAPTED Track MRIdian - Direct Tracking Most accurate soft tissue alignment today Make changes to match daily soft tissue anatomy See what you treat as you treat 8
9 Reshaping the dose with MRI on-table adaptive NSCLC Adrenal Metastasis treatment Original Plan Day of Treatment Today s standard is to use this initial plan every day of the treatment Henke et al. Int J Radiation Oncol Biol Phys, Vol. 96, No. 5, pp. 1078e1086, 2016
10 Reshaping the dose with MRI on-table adaptive NSCLC Adrenal Metastasis treatment Original Plan Day of Treatment Today radiation is often delivered this way missing parts of the target and irradiating healthy tissue Best case, some technologies will detect the move, but not the changed shape Today s standard is to use this initial plan every day of the treatment MRIdian shows tumor has moved significantly and changed shape Henke et al. Int J Radiation Oncol Biol Phys, Vol. 96, No. 5, pp. 1078e1086, 2016
11 Reshaping the dose with MRI on-table adaptive NSCLC Adrenal Metastasis treatment Original Plan Day of Treatment Just accounting for the shift is only part of the story The tumor has also changed shape Only ViewRay s Adaptive planning can RESHAPE the prescription Matching the tumor s shape and position All without moving the patient Henke et al. Int J Radiation Oncol Biol Phys, Vol. 96, No. 5, pp. 1078e1086, 2016
12 Reshaping the dose with MRI on-table adaptive NSCLC Adrenal Metastasis treatment Original Plan Day of Treatment This is the plan that was expected to be delivered every day for the duration of the treatment This is what the MRIdian saw the first day of treatment, the tumor has moved significantly to the right Just accounting for Only ViewRay has the Integrated the shift is only software tools to RESHAPE the part of the story, prescription to match the tumor s since the tumor shape and position RIGHT BEFORE has also changed TREATMENT shape With this unique capability clinicians can further increase dose without increasing toxicity and that has exciting benefits Henke et al. Int J Radiation Oncol Biol Phys, Vol. 96, No. 5, pp. 1078e1086, 2016
13 Clinical benefits of adaptive and higher dose Updated pancreas data presented here at ASTRO 2017 Compelling early results from higher doses delivered through adaptive planning Overall Survival Retrospective data on locally advanced Pancreatic cancer from UCLA, UW, VUMC, & Wash U ViewRay announced a multi-institutional prospective clinical trial on (Primary) Toxicity N=23, BED >90 - on-table adapted N=19, BED <90 non--adapted (Secondary) Overall Survival Higher Maximum Biologic Effective Dose Utilizing Adaptive MRI Guided Radiation Therapy Improves Survival of Inoperable Pancreatic Cancer Patients Rudra S, Jiang N, Rosenberg S, Olsen J, Lagerwaard F, Bruynzeel A, Parikh P, Bassetti M, Lee P; ASTRO
14 Clinical benefits of adaptive and higher dose Updated pancreas data presented here at ASTRO 2017 Compelling early results from higher doses delivered through adaptive planning Overall Survival Retrospective data on locally advanced Pancreatic cancer from UCLA, UW, VUMC, & Wash U The LAP07 Randomized Clinical Trial Pascal Hammel, MD 1 ; Florence Huguet, MD 2 ; Jean- Luc van Laethem, MD 3 ; et al ViewRay announced a multi-institutional prospective clinical trial on (Primary) Toxicity N=23, BED >90 - on-table adapted N=19, BED <90 non--adapted (Secondary) Overall Survival Higher Maximum Biologic Effective Dose Utilizing Adaptive MRI Guided Radiation Therapy Improves Survival of Inoperable Pancreatic Cancer Patients Rudra S, Jiang N, Rosenberg S, Olsen J, Lagerwaard F, Bruynzeel A, Parikh P, Bassetti M, Lee P; ASTRO
15 Latest clinical proof of MRIdian value Presented at ASTRO 2017 Outcomes Utilizing MRI-guided and Real-Time Adaptive Pancreas Stereotactic Body Radiotherapy (SBRT) Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Tumors Stereotactic MR-Guided Adaptive Radiotherapy (SMART) for Ultra-Central Thorax Lesions: Results of a Phase 1 Trial Differential Response Rates of Gastrointestinal Tumors During Real-timeMRI-Guided Radiation Therapy: Opportunities for TreatmentIndividualization Treatment Plan Quality of Tri-Co-60 Intensity Modulated Radiation Therapy Compared to Volumetric Modulated Arc Therapy for Cervical Cancer Towards Tumor Margins Reduction: Tracking Accuracy Evaluation of an MRI-RT System 15
16 Ready for all cancer centers MRIdian treats the full range of cancers handled by conventional linacs Right Breast Mediastinum Head/Neck Right Lung Bladder Mesenteric Aortic Arch Hilum Soft Tissue ABD Pancreas Mediastinal LN Adrenal Rib Pelvic LN Paraaortic Liver Iliac Stomach Spine Soft Tissue Neck Left Lung Spleen Colon Periaortic Left Breast Prostate Soft Tissue Pelvis Rectum Confidential Information 1 16
17 Ready for all cancer centers MRIdian treats the full range of cancers handled by conventional linacs MRIdian advantages in breast, prostate, and lung (60% of radiotherapy cases) 100% Good to Excellent Cosmesis >50% reduction in overall dose 17
18 Ready for all cancer centers MRIdian treats the full range of cancers handled by conventional linacs MRIdian advantages in breast, prostate, and lung (60% of radiotherapy cases) Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) for Prostate Cancer Poster Number:3626 ASTRO 2017 Authors: F. Lagerwaard, A. Bruynzeel, S. Tetar, S. S. Oei, C. Haasbeek, B. J. Slotman, S. Senan, O. Bohoudi, and M. Palacios; VU University Medical Center, Amsterdam, Netherlands Daily re-optimization is mandatory to ensure appropriate target coverage when performing prostate SBRT with 3mm CTV to PTV margins, even with ideal pre-treatment setup. 18
19 Ready for all cancer centers MRIdian treats the full range of cancers handled by conventional linacs MRIdian advantages in breast, prostate, and lung (60% of radiotherapy cases) ASTRO 2017 Stereotactic MR-Guided Adaptive Radiotherapy (SMART) for Ultra-Central Thorax Lesions: Results of a Phase 1 Trial Session Title:eP 18 : Lung eposter Discussion 2 - SBRT Date:9/27/ Time:3:15 p.m. - 4:45 p.m. Presentation Number:1152 AuthorsL. E. Henke 1, R. Kashani 2, O. L. Green 3, A. Curcuru 1, M. C. Roach Jr 4, S. Mutic 3, J. Michalski 4, P. J. Parikh 4, J. D. Bradley 3, J. R. Olsen 3, and C. G. Robinson 4 ; 1 Washington University, St. Louis, MO, Parkview Place, Saint Louis, MO, 3 Washington University School of Medicine, St. Louis, MO, 4 Washington University School of Medicine, Department of Radiation Oncology, St. Louis, MO SMART allows PTV coverage improvement and/or OAR sparing compared to non-adaptive SBRT, and may widen the therapeutic index of UCT SBRT. This technique is clinically feasible and offers excellent local control with no observed acute Grade>=3 toxicity. Impact of Daily Adaptive Plans for Stereotactic MR-Guided Radiation Therapy (SMART) in Early Stage Lung Cancer Poster Number:3713 Authors: S. Senan, S. Tetar, O. Bohoudi, M. Palacios, B. J. Slotman, A. Bruynzeel, and F. Lagerwaard; VU University Medical Center, Amsterdam, Netherlands 19
20 Ready for all cancer centers MRIdian treats the full range of cancers handled by conventional linacs MRIdian advantages in breast, prostate, and lung (60% of radiotherapy cases) MRIdian s RayZR MLC and sharp edged beams enable Radiosurgery 20
21 Value of adaptive therapy recognized with reimbursement Hospitals and physicians receiving extra when anatomical changes necessitate a revised plan using existing codes (over 3 years experience) With better visualization patients can be treated in fewer fractions (IMRT to SBRT) reducing overall cost of care SBRT (5 Fx) IMRT (30 Fx) $24,045 Revenue per Patient $11,213 $19,792 Revenue per Patient $17,636 VMAT MRIdian (3 replan) VMAT MRIdian (2 replan) 21
22 With shorter, high dose treatments - everybody wins Patients receive shorter courses of treatment Physicians recognize potential of high dose SBRT Hospitals and free-standing clinics gain capacity Payors pay less per patient ViewRay customers positioned well for shift to value-based payment system SBRT 3D Conf IMRT Other Projected Market Growth of SBRT 6% 41% 13% 40% % 45% 18% 32% 1 Morgan Stanley Research; Global Medical Devices April 7, 2016, 2 As reported by centers shown here 1 43% % MRIdian SBRT Utilization 2-3x Higher 5% 95% 51% 45% 65% 4% 35% 2 30% 48% 22% 47% 46% 7% 22
23 ViewRay well positioned competitively Continuous MRI instead of poor contrast X-rays Unique on table adaptive capability Fits into existing vaults Standard Linac Elekta Research MRIdian Linac Elekta Vault size No MRI Massive, no regulatory clearance and costly construction 23 Plug-and-Play
24 ViewRay well positioned competitively Continuous MRI instead of poor contrast X-rays Unique on table adaptive capability Fits into existing vaults Standard Linac Elekta Research MRIdian Linac Standard Linac Vault size No MRI Massive, no regulatory clearance and costly construction 24 Plug-and-Play
25 ViewRay well positioned competitively Continuous MRI instead of poor contrast X-rays Unique on table adaptive capability Fits into existing vaults Standard Linac Elekta Research MRIdian Linac Standard Linac Vault size No MRI Massive, no regulatory clearance and costly construction 25 Plug-and-Play
26 5 key takeaways 3+ years of clinical experience show clear advantages of MRI guided RT Only system to adapt and reshape the dose with patient on-table Unique 4 Tesla quality imaging at the right (RT) field strength for therapy Henry Ford Health Center treating with MRIdian Linac since July Reiterating guidance of $45-$50M on 7-8 systems by year end ViewRay believes that we will enable a new standard of cancer care. 26
27 A New Standard of Care ASTRO 2017 Update (NASDAQ: VRAY) 27
Practical implementation of MR-guided RT: pancreatic SBRT as an example site
Practical implementation of MR-guided RT: pancreatic SBRT as an example site Anna Bruynzeel, MD PhD Dept. of Radiation Oncology VU University medical center Amsterdam, The Netherlands VU University Medical
More informationDepartment of Radiation Oncology SMART. Stereotactic MR-guided adaptive radiotherapy. Marloes Jeulink Omar Bohoudi
SMART Stereotactic MR-guided adaptive radiotherapy Department of Radiation Oncology Marloes Jeulink Omar Bohoudi First clinical treatment May 4th 2016 First clinical treatment May 4 th 2016 MR-guided RT
More information8/1/2017. Clinical Indications and Applications of Realtime MRI-Guided Radiotherapy
Clinical Indications and Applications of Realtime MRI-Guided Radiotherapy Michael F Bassetti MD PhD Assistant Professor, Department of Human Oncology University of Wisconsin, Madison. Carbone Cancer Center
More informationMRIdian. Linac Advantage. For distribution in the United States
MRIdian Linac Advantage For distribution in the United States MRI + LINAC THE FUTURE IS HERE SIMULTANEOUS IMAGING AND TREATMENT because organ motion matters Visibly Different It is a simple truth. Voluntary
More informationStereotactic MR-guided adaptive radiation therapy (SMART) for locally advanced pancreatic tumors
Stereotactic MR-guided adaptive radiation therapy (SMART) for locally advanced pancreatic tumors Anna Bruynzeel, Radiation Oncologist VU University Medical Center, Amsterdam, The Netherlands Current standard
More informationThe MRIdian Advantage
The MRIdian Advantage SIMULTANEOUS IMAGING AND TREATMENT because organ motion matters Visibly Different It is a simple truth. Involuntary life-sustaining movements don t stop while your patients are receiving
More informationPartial Breast Irradiation using adaptive MRgRT
Partial Breast Irradiation using adaptive MRgRT Shyama Tetar, radiation-oncologist VUmc Amsterdam 15-12-2017 5 th Vumc SBRT symposium 2017 Current practice Breast conserving treatment (BCT) Breast conserving
More informationElekta Synergy Digital accelerator for advanced IGRT
Elekta Synergy Digital accelerator for advanced IGRT Setting the standard for confident care The Field of Radiation Therapy is Constantly Changing Being able to take full advantage of the latest clinical
More informationIMRT - the physician s eye-view. Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia
IMRT - the physician s eye-view Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia The goals of cancer therapy Local control Survival Functional status Quality of life Causes
More informationAdvances in external beam radiotherapy
International Conference on Modern Radiotherapy: Advances and Challenges in Radiation Protection of Patients Advances in external beam radiotherapy New techniques, new benefits and new risks Michael Brada
More informationEvaluation of Monaco treatment planning system for hypofractionated stereotactic volumetric arc radiotherapy of multiple brain metastases
Evaluation of Monaco treatment planning system for hypofractionated stereotactic volumetric arc radiotherapy of multiple brain metastases CASE STUDY Institution: Odette Cancer Centre Location: Sunnybrook
More informationIt s All About Margins. Maaike Milder, Ph.D. Accuray Symposium April 21 st 2018
It s All About Margins Maaike Milder, Ph.D. Accuray Symposium April 21 st 2018 Why margins? The smaller the better! Short Introduction Erasmus MC has been using the CyberKnife Robotic Radiosurgery System
More informationJean Pouliot, PhD Professor and Vice Chair, Department of Radiation Oncology, Director of Physics Division
IMRT / Tomo / VMAT / Cyberknife / HDR Brachytherapy: Jean Pouliot, PhD Professor and Vice Chair, Department of Radiation Oncology, Director of Physics Division Should Choices be Based on Dosimetric and
More informationMRI Applications in Radiation Oncology:
MRI Applications in Radiation Oncology: Physician s Perspective Jeff Olsen, MD Department of Radiation Oncology Washington University, St. Louis, MO Disclosures Washington University has research and service
More informationOriginal Date: April 2016 Page 1 of 7 FOR CMS (MEDICARE) MEMBERS ONLY
National Imaging Associates, Inc. Clinical guidelines STEREOTACTIC RADIATION THERAPY: STEREO RADIOSURGERY (SRS) AND STEREOTACTIC BODY RADIATION THERAPY (SBRT) CPT4 Codes: Please refer to pages 5-6 LCD
More informationMotion gating and tracking techniques: overview and recent developments
Motion gating and tracking techniques: overview and recent developments Gig S Mageras, PhD, FAAPM Department of Medical Physics Memorial Sloan Kettering Cancer Center, New York MSK/gsm 15-Jun-2018 1 Disclosure
More informationSubject: Image-Guided Radiation Therapy
04-77260-19 Original Effective Date: 02/15/10 Reviewed: 01/25/18 Revised: 01/01/19 Subject: Image-Guided Radiation Therapy THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION, CERTIFICATION, EXPLANATION
More informationElekta R&D Update 22 January 2015, Utrecht
1 Elekta R&D Update 22 January 2015, Utrecht Elekta R&D Update - 22 January 2015, Utrecht 11.00 R&D Update Niklas Savander President and CEO 11.15 Atlantic Positioning Dee Mathieson, SVP Oncology Business
More informationClinical Precision for Best Cancer Care. Dee Mathieson Senior Vice President Oncology Business Line Management
Clinical Precision for Best Cancer Care Dee Mathieson Senior Vice President Oncology Business Line Management Optimizing clinical results Key drivers in modern Radiation Therapy Clinical precision Continuous
More informationFuture of Radiation Therapy
Future of Radiation Therapy JP Morgan Healthcare Conference January 12, 2016 Deepak Khuntia, MD, VP of Medical Affairs Patrick Kupelian, MD, VP of Clinical Affairs Cancer as a cause of death CANCER TREATMENT
More information8/2/2018. Disclosure. Online MR-IG-ART Dosimetry and Dose Accumulation
Online MR-IG-ART Dosimetry and Dose Accumulation Deshan Yang, PhD, Associate Professor Department of Radiation Oncology, School of Medicine Washington University in Saint Louis 1 Disclosure Received research
More informationDosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer
Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer Tan Chek Wee 15 06 2016 National University Cancer Institute, Singapore Clinical Care Education Research
More informationStereotactic Ablative Radiotherapy for Prostate Cancer
Stereotactic Ablative Radiotherapy for Prostate Cancer Laurie Cuttino, MD Associate Professor of Radiation Oncology VCU Massey Cancer Center Director of Radiation Oncology Sarah Cannon Cancer Center at
More informationLinac or Non-Linac Demystifying And Decoding The Physics Of SBRT/SABR
Linac or Non-Linac Demystifying And Decoding The Physics Of SBRT/SABR PhD, FAAPM, FACR, FASTRO Department of Radiation Oncology Indiana University School of Medicine Indianapolis, IN, USA Indra J. Das,
More informationStereotactic Radiosurgery. Extracranial Stereotactic Radiosurgery. Linear accelerators. Basic technique. Indications of SRS
Stereotactic Radiosurgery Extracranial Stereotactic Radiosurgery Annette Quinn, MSN, RN Program Manager, University of Pittsburgh Medical Center Using stereotactic techniques, give a lethal dose of ionizing
More informationFlattening Filter Free beam
Dose rate effect in external radiotherapy: biology and clinic Marta Scorsetti, M.D. Radiotherapy and Radiosurgery Dep., Istituto Clinico Humanitas, Milan, Italy Brescia October 8th/9th, 2015 Flattening
More informationOverview of Advanced Techniques in Radiation Therapy
Overview of Advanced Techniques in Radiation Therapy Jacob (Jake) Van Dyk Manager, Physics & Engineering, LRCP Professor, UWO University of Western Ontario Acknowledgements Glenn Bauman Jerry Battista
More informationCBCT of the patient in the treatment position has gained wider applications for setup verification during radiotherapy.
Gülcihan CÖDEL Introduction The aim of this study is to evaluate the changes in bladder doses during the volumetric modulated arc therapy (VMAT) treatment of prostate cancer patients using weekly cone
More informationGlobal Radiation Therapy Market Report
Global Radiation Therapy Market Report ----------------------------------------- 2013 Executive Summary Radiotherapy is used to kill cancerous cells and is commonly used either alone or in combination
More informationDisclosures. Overview 8/3/2016. SRS: Cranial and Spine
SRS: Cranial and Spine Brian Winey, Ph.D. Department of Radiation Oncology Massachusetts General Hospital Harvard Medical School Disclosures Travel and research funds from Elekta Travel funds from IBA
More informationElekta - a partner and world-leading supplier
Experience Elekta Elekta - a partner and world-leading supplier of clinical solutions for image guided radiation therapy, stereotactic radiotherapy, radiosurgery and brachytherapy, as well as advanced
More informationMedical Dosimetry Graduate Certificate Program IU Graduate School & The Department of Radiation Oncology IU Simon Cancer Center
Medical Dosimetry Graduate Certificate Program IU Graduate School & The Department of Radiation Oncology IU Simon Cancer Center All students accepted into the Medical Dosimetry Graduate Certificate Program
More informationFROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE. Geoffrey S. Ibbott, Ph.D. June 20, 2017
FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE Geoffrey S. Ibbott, Ph.D. June 20, 2017 1 DISCLOSURES My institution holds Strategic Partnership Research Agreements with Varian, Elekta, and Philips
More informationWhat is the CyberKnife System?
CYBERKNIFE Robotic Radiosurgery System PATIENT BROChURE What is the CyberKnife System? have stabilizing frames bolted to their head or limit their breathing during treatment to minimize movement of the
More informationLinac Based SBRT for Low-intermediate Risk Prostate Cancer in 5 Fractions: Preliminary Report of a Phase II Study with FFF Delivery
Linac Based SBRT for Low-intermediate Risk Prostate Cancer in 5 Fractions: Preliminary Report of a Phase II Study with FFF Delivery FILIPPO ALONGI MD Radiation Oncology & Radiosurgery Istituto Clinico
More informationRadiation Therapy: From Fallacy to Science
27 th Annual Management of Colon and Rectal Diseases 2.23.2019 Radiation Therapy: From Fallacy to Science Hadi Zahra, MD, DABR Radiation Oncologist CHI Health Henry Lynch Cancer Center Assistant Clinical
More informationMargins in SBRT. Mischa Hoogeman
Margins in SBRT Mischa Hoogeman MARGIN CONCEPTS Why do we use margins? Target / tumor To a-priori compensate for (unknown) deviations between the intended target position and the real target position during
More informationA TREATMENT PLANNING STUDY COMPARING VMAT WITH 3D CONFORMAL RADIOTHERAPY FOR PROSTATE CANCER USING PINNACLE PLANNING SYSTEM *
Romanian Reports in Physics, Vol. 66, No. 2, P. 394 400, 2014 A TREATMENT PLANNING STUDY COMPARING VMAT WITH 3D CONFORMAL RADIOTHERAPY FOR PROSTATE CANCER USING PINNACLE PLANNING SYSTEM * D. ADAM 1,2,
More informationSUPERIORITY OF A REAL TIME PLANNING TECHNIQUE OVER IMAGE GUIDED RADIATION THERAPY FOR THE TREATMENT OF PRIMARY PROSTATE CANCERS
SUPERIORITY OF A REAL TIME PLANNING TECHNIQUE OVER IMAGE GUIDED RADIATION THERAPY FOR THE TREATMENT OF PRIMARY PROSTATE CANCERS Authors: Scott Merrick James Wong MD, Mona Karim MD, Yana Goldberg MD DISCLOSURE
More informationLung SBRT in a patient with poor pulmonary function
Lung SBRT in a patient with poor pulmonary function CASE STUDY Delivered using Versa HD with High Dose Rate mode and Symmetry 4D image guidance Institution: Department of Oncology, Odense University Hospital
More informationAdvanced Tumor Treatment
Advanced Tumor Treatment What is CyberKnife? The CyberKnife Stereotactic Radiosurgery System, offered by Southwest Washington Medical Center, is a noninvasive outpatient treatment without the risks and
More informationIntegrating the Radixact into a Highly Comprehensive Center
Integrating the Radixact into a Highly Comprehensive Center Alonso N. Gutiérrez, PhD, MBA ASTRO Meeting 2018 Disclosures An honorarium is provided by Accuray for this presentation (donated) Accuray and
More informationThis LCD recognizes these two distinct treatment approaches and is specific to treatment delivery:
National Imaging Associates, Inc. Clinical guidelines STEREOTACTIC RADIOSURGERY (SRS) AND STEREOTACTIC BODY RADIATION THERAPY (SBRT) CPT4 Codes: 77371, 77372, 77373 LCD ID Number: L33410 J-N FL Responsible
More informationClinical experience with TomoDirect System Tangential Mode
Breast Cancer Clinical experience with TomoDirect System Tangential Mode European Institute of Oncology Milan, Italy Disclosure & Disclaimer An honorarium is provided by Accuray for this presentation The
More informationClinical Implications Of Dose Summation And Adaptation
Clinical Implications Of Dose Summation And Adaptation Patrick Kupelian, M.D. Professor and Vice Chair University of California Los Angeles Department of Radiation Oncology pkupelian@mednet.ucla.edu August
More informationAn introduction to different types of radiotherapy
An introduction to different types of radiotherapy Radiotherapy can cure cancer. It is delivered to around half of cancer patients and is a vital part of curative treatment in around 40% of patients 1.
More informationThe Physics of Oesophageal Cancer Radiotherapy
The Physics of Oesophageal Cancer Radiotherapy Dr. Philip Wai Radiotherapy Physics Royal Marsden Hospital 1 Contents Brief clinical introduction Imaging and Target definition Dose prescription & patient
More informationJP MORGAN HEALTHCARE CONFERENCE DOW R. WILSON President and Chief Executive Officer 1 FOR INVESTOR USE ONLY
JP MORGAN HEALTHCARE CONFERENCE - 2017 DOW R. WILSON President and Chief Executive Officer 1 FOR INVESTOR USE ONLY THIS PRESENTATION IS INTENDED EXCLUSIVELY FOR INVESTORS. IT IS NOT INTENDED FOR USE IN
More informationStereotactic ablative radiotherapy in early NSCLC and metastases
Stereotactic ablative radiotherapy in early NSCLC and metastases Scheduled: 0810-0830 hrs, 10 March 2012 Professor Suresh Senan Department of Radiation Oncology SABR in stage I NSCLC A major treatment
More informationEfficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO
Investigations and research Efficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO M. Kunze-Busch P. van Kollenburg Department of Radiation Oncology, Radboud University Nijmegen Medical
More informationCURRENT ADVANCES IN RADIATION THERAPY
CURRENT ADVANCES IN RADIATION THERAPY ESMO Summit Africa 2018 Suresh Senan Radiation oncologist, VU University medical center Amsterdam, The Netherlands CONFLICT OF INTEREST DISCLOSURE Research grants:
More informationTecniche Radioterapiche U. Ricardi
Tecniche Radioterapiche U. Ricardi UNIVERSITA DEGLI STUDI DI TORINO Should we always rely on stage? T4N0M0 Stage IIIB T2N3M0 Early stage NSCLC The treatment of choice for early-stage NSCLC is anatomic
More informationChanging Paradigms in Radiotherapy
Changing Paradigms in Radiotherapy Marco van Vulpen, MD, PhD Mouldroomdag-2015 Towards the elimination of invasion 1 NIH opinion on the future of oncology Twenty-five years from now,i hope that we won
More informationTreatment Planning & IGRT Credentialing for NRG SBRT Trials
Treatment Planning & IGRT Credentialing for NRG SBRT Trials Hania Al Hallaq, Ph.D. Department of Radiation & Cellular Oncology The University of Chicago Learning Objectives Explain rationale behind credentialing
More informationStereotactic Body Radiotherapy for Lung Lesions using the CyberKnife of-the-art and New Innovations
Stereotactic Body Radiotherapy for Lung Lesions using the CyberKnife State-of of-the-art and New Innovations Chad Lee, PhD CK Solutions, Inc. and CyberKnife Centers of San Diego Outline Basic overview
More informationElekta Infinity Digital accelerator for advanced treatments
Elekta Infinity Digital accelerator for advanced treatments Redefining treatment precision, speed and control Confidence to increase conformance and speed without compromising target coverage Set yourself
More informationOutline. Contour quality control. Dosimetric impact of contouring errors and variability in Intensity Modulated Radiation Therapy (IMRT)
Dosimetric impact of contouring errors and variability in Intensity Modulated Radiation Therapy (IMRT) James Kavanaugh, MS DABR Department of Radiation Oncology Division of Medical Physics Outline Importance
More informationA treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse
Peters et al. Radiation Oncology 2014, 9:153 RESEARCH Open Access A treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse Samuel Peters
More informationPage 1. Helical (Spiral) Tomotherapy. UW Helical Tomotherapy Unit. Helical (Spiral) Tomotherapy. MVCT of an Anesthetized Dog with a Sinus Tumor
Helical (Spiral) Tomotherapy Novel Clinical Applications of IMRT Linac Ring Gantry CT Detector X-Ray Fan Beam Binary Multileaf Collimator Binary MLC Leaves James S Welsh, MS, MD Department of Human Oncology
More informationTechnology Challenges of Commercial Medical Electron Accelerators
Technology Challenges of Commercial Medical Electron Accelerators John Allen Chief Engineer Elekta Ltd Aims of this talk Medical Radiotherapy is already a large and profitable business Well established
More informationTHE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS
THE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS ICTP SCHOOL ON MEDICAL PHYSICS FOR RADIATION THERAPY DOSIMETRY AND TREATMENT PLANNING FOR BASIC AND ADVANCED APPLICATIONS March
More informationAnnual Shareholders Meeting
Annual Shareholders Meeting February 8, 2018 Dow R. Wilson, President and Chief Executive Officer Forward-Looking Statements Except for historical information, this presentation contains forward-looking
More informationCorporate Medical Policy
Corporate Medical Policy Intensity Modulated Radiation Therapy (IMRT) of Abdomen and File Name: Origination: Last CAP Review: Next CAP Review: Last Review: intensity_modulated_radiation_therapy_imrt_of_abdomen_and_pelvis
More informationStereotactic MR-guided adaptive radiotherapy for central lung tumors. Professor Suresh Senan, VU University Medical Center
Stereotactic MR-guided adaptive radiotherapy for central lung tumors Professor Suresh Senan, VU University Medical Center Disclosures Research grants: Varian Medical Systems, ViewRay Inc. Advisory boards:
More informationSBRT TREATMENT PLANNING: TIPS + TRICKS. Rachel A. Hackett CMD, RT(T)
SBRT TREATMENT PLANNING: TIPS + TRICKS Rachel A. Hackett CMD, RT(T) OUTLINE Brief radiobiology review 3D CRT Tx Planning VMAT Tx Planning Protocols Other Sites Oligomets Spine Liver Kidney Adrenal Gland
More informationNational System for Incident Reporting in Radiation Therapy (NSIR-RT) Taxonomy
Canadian Partnership for Quality Radiotherapy (CPQR) National System for Incident Reporting in Radiation Therapy (NSIR-RT) National System for Incident Reporting in Radiation Therapy (NSIR-RT) Taxonomy
More informationINVESTOR MEETING ASTRO 2013
INVESTOR MEETING ASTRO 2013 Webcast will begin 7:15 a.m. EDT SEPTEMBER 24, 2013 2013 VARIAN MEDICAL SYSTEMS. ALL RIGHTS RESERVED. Forward-Looking Statements Except for historical information, this news
More informationCorporate Medical Policy
Corporate Medical Policy Intensity Modulated Radiation Therapy (IMRT) of Head and Neck File Name: Origination: Last CAP Review: Next CAP Review: Last Review: intensity_modulated_radiation_therapy_imrt_of_head_and_neck
More informationIGRT Solution for the Living Patient and the Dynamic Treatment Problem
IGRT Solution for the Living Patient and the Dynamic Treatment Problem Lei Dong, Ph.D. Associate Professor Dept. of Radiation Physics University of Texas M. D. Anderson Cancer Center Houston, Texas Learning
More informationIntensity-Modulated and Image- Guided Radiation Treatment. Outline. Conformal Radiation Treatment
Intensity-Modulated and Image- Guided Radiation Treatment J. Daniel Bourland, PhD Professor Departments of Radiation Oncology, Physics, and Biomedical Engineering Wake Forest University School of Medicine
More informationA Patient s Guide to SRS
A Patient s Guide to SRS Stereotactic Radiosurgery 230 Nebraska St. Sioux City, IA 51101 NOTES 230 Nebraska St. Sioux City, IA 51101 Contents page Introduction 1 SRS and how it works 2 The technology involved
More informationPRECISE, ROBOTIC TREATMENT AS INDIVIDUAL AS EVERY PATIENT
PRECISE, ROBOTIC TREATMENT AS INDIVIDUAL AS EVERY PATIENT BENEFITS OF THE CYBERKNIFE TREATMENT DELIVERY SYSTEM True robotic precision: Enable high definition radiotherapy anywhere in the body with the
More informationAutomated Plan Quality Check with Scripting. Rajesh Gutti, Ph.D. Clinical Medical Physicist
Automated Plan Quality Check with Scripting Rajesh Gutti, Ph.D. Clinical Medical Physicist Veera.Gutti@BSWHealth.org Outline Introduction - BSW Automation in Treatment planning Eclipse Scripting API Script
More informationRadiation Oncology. The conf ident path to treatment Philips Radiation Oncology Solutions
Radiation Oncology The conf ident path to treatment Philips Radiation Oncology Solutions The confident path to treatment Philips Radiation Oncology Solutions Imaging Image registration Contouring Treatment
More informationCorporate Presentation Fourth Quarter 2017
Corporate Presentation Fourth Quarter 2017 November 2017 1 Safe harbor statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as
More informationNIA MAGELLAN HEALTH RADIATION ONCOLOGY CODING STANDARD. Dosimetry Planning
NIA MAGELLAN HEALTH RADIATION ONCOLOGY CODING STANDARD Dosimetry Planning CPT Codes: 77295, 77300, 77301, 77306, 77307, 77321, 77316, 77317, 77318, 77331, 77399 Original Date: April, 2011 Last Reviewed
More informationThe Evolution of RT Techniques for Gynaecological Cancers in a developing country context
The Evolution of RT Techniques for Gynaecological Cancers in a developing country context Hannah Simonds Stellenbosch University/ Tygerberg Academic Hospital ESMO Africa 2017 I have no disclosures External
More informationJanuary 30, 2018 Dow Wilson President and Chief Executive Officer
Acquisition of SIRTeX January 30, 2018 Dow Wilson President and Chief Executive Officer This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Forward-Looking
More information- In potentially operable patients -
Lung Stereotactic Ablative Radiotherapy (SABR) - In potentially operable patients - Frank Lagerwaard VUMC Amsterdam Stereotactic Ablative Radiotherapy (SABR) 2003-2008 4DCT-based target definition Non-gated
More informationImplementing New Technologies for Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Implementing New Technologies for Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Implementation of radiosurgery and SBRT requires a fundamentally sound approach Errors don t blur out
More informationEconomic Implications of Advancements in Radiation Technology. Dramatic Growth of RT Capacity in the US
Economic Implications of Advancements in Radiation Technology Sponsored by: OTN Anthony M. Berson, M.D. Radiation Oncology, St. Vincent s Comprehensive Cancer Center Richard Emery Vice President, Aptium
More informationThe role of Radiation Oncologist: Hi-tech treatments for liver metastases
The role of Radiation Oncologist: Hi-tech treatments for liver metastases Icro Meattini, MD Radiotherapy-Oncology Unit AOU Careggi Hospital Florence University, Italy Liver Metastases - Background The
More informationMerck Announces FDA Approval of KEYTRUDA. Provided to Investors as a Reference
Merck Announces FDA Approval of KEYTRUDA Provided to Investors as a Reference Forward-Looking Statement This presentation includes forward-looking statements within the meaning of the safe harbor provisions
More informationUNIVERSITY OF WISCONSIN-LA CROSSE Graduate Studies
UNIVERSITY OF WISCONSIN-LA CROSSE Graduate Studies A SINGLE INSTITUTION S EXPERIENCE IN DEVELOPING A PURPOSEFUL AND EFFICIENT OFF-LINE TECHNIQUE FOR ADAPTIVE RADIOTHERAPY IN A CLINICAL ENVIRONMENT A Research
More informationSmall-Cap Research. Viewray Inc (VRAY-NASDAQ) VRAY: Q Financial Results. Anticipating More Than $40 Million In Revenues In 2017 OUTLOOK
Small-Cap Research August 9, 2017 Anita Dushyanth, PhD 312-265-9434/adushyanth@zacks.com Brian Marckx, CFA 312-265-9474/bmarckx@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Viewray
More information7/31/2012. Volumetric modulated arc therapy. UAB Department of Radiation Oncology. Richard Popple, Ph.D.
UAB Department of Radiation Oncology Volumetric modulated arc therapy Richard Popple, Ph.D. Disclosures UAB has research agreements with Varian Medical Systems Speaking honoraria from Varian Medical Systems
More informationSHIELDING TECHNIQUES FOR CURRENT RADIATION THERAPY MODALITIES
SHIELDING TECHNIQUES FOR CURRENT RADIATION THERAPY MODALITIES MELISSA C. MARTIN, M.S., FACR, FAAPM PRESIDENT AAPM - 2017 PRESIDENT - THERAPY PHYSICS INC., GARDENA, CA MELISSA@THERAPYPHYSICS.COM AAPM Spring
More informationNCCN GUIDELINES ON PROTON THERAPY (AS OF 4/23/18) BONE (Version , 03/28/18)
BONE (Version 2.2018, 03/28/18) NCCN GUIDELINES ON PROTON THERAPY (AS OF 4/23/18) Radiation Therapy Specialized techniques such as intensity-modulated RT (IMRT); particle beam RT with protons, carbon ions,
More informationThe TomoTherapy System as a Tool of Differentiation in Quality and Marketability
The TomoTherapy System as a Tool of Differentiation in Quality and Marketability John J. Kresl, MD, PhD, FACRO, FACR Medical Director Phoenix CyberKnife & Radiation Oncology Center Managing Partner Phoenix,
More informationART for Cervical Cancer: Dosimetry and Technical Aspects
ART for Cervical Cancer: Dosimetry and Technical Aspects D.A. Jaffray, Ph.D. Radiation Therapy Physics Princess Margaret Cancer Centre/Techna/Ontario Cancer Institute Professor Departments of Radiation
More information4D Radiotherapy in early ca Lung. Prof. Manoj Gupta Dept of Radiotherapy & oncology I.G.Medical College Shimla
4D Radiotherapy in early ca Lung Prof. Manoj Gupta Dept of Radiotherapy & oncology I.G.Medical College Shimla Presentation focus on ---- Limitation of Conventional RT Why Interest in early lung cancer
More informationClinical Implementation of a New Ultrasound Guidance System. Vikren Sarkar Bill Salter Martin Szegedi
Clinical Implementation of a New Ultrasound Guidance System Vikren Sarkar Bill Salter Martin Szegedi Disclosure The University of Utah has research agreements with Elekta Agenda Historical Review Trans-Abdominal
More informationCURRICULUM OUTLINE FOR TRANSITIONING FROM 2-D RT TO 3-D CRT AND IMRT
CURRICULUM OUTLINE FOR TRANSITIONING FROM 2-D RT TO 3-D CRT AND IMRT Purpose The purpose of this curriculum outline is to provide a framework for multidisciplinary training for radiation oncologists, medical
More informationHot topics in Radiation Oncology for the Primary Care Providers
Hot topics in Radiation Oncology for the Primary Care Providers Steven Feigenberg, MD Professor Chief, Thoracic Oncology Vice Chair of Clinical Research April 19, 2018 Disclosures NONE 2 Early Stage Disease
More informationNew Technologies for the Radiotherapy of Prostate Cancer
Prostate Cancer Meyer JL (ed): IMRT, IGRT, SBRT Advances in the Treatment Planning and Delivery of Radiotherapy. Front Radiat Ther Oncol. Basel, Karger, 27, vol. 4, pp 315 337 New Technologies for the
More informationMRI Based treatment planning for with focus on prostate cancer. Xinglei Shen, MD Department of Radiation Oncology KUMC
MRI Based treatment planning for with focus on prostate cancer Xinglei Shen, MD Department of Radiation Oncology KUMC Overview How magnetic resonance imaging works (very simple version) Indications for
More informationCredentialing for the Use of IGRT in Clinical Trials
Credentialing for the Use of IGRT in Clinical Trials James M. Galvin, DSc Thomas Jefferson University Hospital Jefferson Medical College Philadelphia, PA and The Radiation Therapy Oncology Group RADIATION
More informationSBRT fundamentals. Outline 8/2/2012. Stereotactic Body Radiation Therapy Quality Assurance Educational Session
Stereotactic Body Radiation Therapy Quality Assurance Educational Session J Perks PhD, UC Davis Medical Center, Sacramento CA SBRT fundamentals Extra-cranial treatments Single or small number (2-5) of
More informationElekta Infinity. Digital accelerator for advanced treatments. Redefining treatment precision, speed and control
Elekta Infinity Digital accelerator for advanced treatments Redefining treatment precision, speed and control Do you have the confidence to increase conformance and speed without compromising target coverage?
More informationtypical IMRT fraction time and expand high definition radiotherapy anywhere in the body with the widest range of motion of the
Precisely maximize dose, Versatile, efficient and effective for the BENEFITS OFandTHE CYBERKNIFE TREATMENT minimize side effects range of radiation oncology patients maximize patient comfort DELIVERY SYSTEM
More information